Robert Esnouf

8.2k citations

77 papers · 6.8k · 2 hit papers · h-index 34

Impact in

Virology top 0.2%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Molecular Biology 47
- Biochemical and Molecular Research 15
- DNA and Nucleic Acid Chemistry 9
- Protein Structure and Dynamics 6
Infectious Diseases 24
- HIV/AIDS drug development and treatment 24

Co-authors: E. Yvonne Jones (17 shared papers)David I. Stuart (29 shared papers)D.K. Stammers (12 shared papers)Jingshan Ren (12 shared papers)Carl Ross (8 shared papers)Erik De Clercq (24 shared papers)Andrew L. Hopkins (6 shared papers)Karl Harlos (9 shared papers)
Journals: Molecular Pharmacology (11 papers)Helvetica Chimica Acta (5 papers)Nature Structural & Molecular Biology (4 papers)Journal of Medicinal Chemistry (4 papers)Journal of Molecular Biology (3 papers)
Partner nations: United Kingdom Belgium Germany

In The Last Decade

Robert Esnouf

77 papers receiving 6.6k citations

Robert Esnouf's Hit Papers

align trajectories log scale

Further additions to MolScript version 1.4, including reading and contouring of electron-density maps 1999 · 733 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1999 Acta Crystallographica Section D Biological Crystallography
1997 Journal of Molecular Graphics and Modelling

Peers

Countries citing papers authored by Robert Esnouf

Since Specialization

Citations

This map shows the geographic impact of Robert Esnouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Esnouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Esnouf more than expected).

Fields of papers citing papers by Robert Esnouf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Esnouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Esnouf. The network helps show where Robert Esnouf may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Esnouf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Esnouf Line = papers co-authored together Robert Esnouf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	An extensively modified version of MolScript that includes greatly enhanced coloring capabilities Journal of Molecular Graphics and Modelling ·Robert Esnouf Hit paper breakdown →	1997	1628
2	Further additions to MolScript version 1.4, including reading and contouring of electron-density maps Acta Crystallographica Section D Biological Crystallography ·Robert Esnouf Hit paper breakdown →	1999	733
3	High resolution structures of HIV-1 RT from four RT–inhibitor complexes Nature Structural & Molecular Biology ·Jingshan Ren, Robert Esnouf, Elspeth F. Garman, D.O. Somers, Carl Ross, Ian Kirby, James Keeling, G. Darby, E. Yvonne Jones, David I. Stuart, D.K. Stammers	1995	437
4	Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors Nature Structural & Molecular Biology ·Robert Esnouf, Jingshan Ren, Carl Ross, E. Yvonne Jones, D.K. Stammers, David I. Stuart	1995	370
5	Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformational Changes Relevant to the Design of Potent Non-Nucleoside Inhibitors Journal of Medicinal Chemistry ·Andrew L. Hopkins, Jingshan Ren, Robert Esnouf, Benjamin E. Willcox, E. Yvonne Jones, Carl Ross, Tadashi Miyasaka, Richard Walker, Hiromichi Tanaka, D.K. Stammers, David I. Stuart	1996	309
6	Gene polymorphism in Netherton and common atopic disease Nature Genetics ·Andrew J. Walley, Stéphane Chavanas, Miriam F. Moffatt, Robert Esnouf, Baljinder Ubhi, Robert Lawrence, Kenny Wong, Gonçalo R. Abecasis, E. Yvonne Jones, John I. Harper, Alain Hovnanian, William O.C.M. Cookson	2001	284
7	Structural and kinetic basis for heightened immunogenicity of T cell vaccines The Journal of Experimental Medicine ·Ji‐Li Chen, Guillaume Stewart-Jones, Giovanna Bossi, Nikolai M. Lissin, Linda Wooldridge, E Choi, Gerhard Held, P. Rod Dunbar, Robert Esnouf, Malkit Sami, Jonathan M. Boulter, P.J. Rizkallah, Christoph Renner, Andrew K. Sewell, P. Anton van der Merwe, Bent K. Jakobsen, Gillian M. Griffiths, E. Yvonne Jones, Vincenzo Cerundolo	2005	219
8	A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization Acta Crystallographica Section D Biological Crystallography ·Thomas S. Walter, Jonathan M. Diprose, Chris Mayo, Christian Siebold, Mike G. Pickford, Lester Carter, Geoff Sutton, (unknown), James Brown, (unknown), Guillaume B. E. Stewart-Jones, Jonathan M. Grimes, D.K. Stammers, Robert Esnouf, E. Yvonne Jones, Raymond J. Owens, David I. Stuart, Karl Harlos	2005	212
9	Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor Proceedings of the National Academy of Sciences ·Robert Esnouf, Jingshan Ren, Andrew L. Hopkins, Carl Ross, E. Yvonne Jones, D.K. Stammers, David I. Stuart	1997	159
10	The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design Structure ·Jingshan Ren, Robert Esnouf, Andrew L. Hopkins, Carl Ross, E. Yvonne Jones, D.K. Stammers, David I. Stuart	1995	150
11	Crystal structure of a soluble CD28-Fab complex Nature Immunology ·Edward J. Evans, Robert Esnouf, Raquel Manso-Sancho, Robert J.C. Gilbert, John R. James, Chao Yu, Janet A. Fennelly, Cheryl Vowles, Thomas Hanke, Björn Walse, Thomas Hünig, Poul Sørensen, David I. Stuart, Simon J. Davis	2005	147
12	The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D Nature Structural & Molecular Biology ·Christopher Love, Karl Harlos, Nasim Mavaddat, Simon J. Davis, David I. Stuart, E. Yvonne Jones, Robert Esnouf	2003	130
13	The sema domain Current Opinion in Structural Biology ·Ermanno Gherardi, Christopher Love, Robert Esnouf, E. Yvonne Jones	2004	121
14	Phenylethylthiazolylthiourea (PETT) Non-nucleoside Inhibitors of HIV-1 and HIV-2 Reverse Transcriptases Journal of Biological Chemistry ·Jingshan Ren, Jonathan M. Diprose, Jonathan Warren, Robert Esnouf, Louise E. Bird, Shinji Ikemizu, Martin J. Slater, John Milton, Jan Balzarini, David I. Stuart, D.K. Stammers	2000	102
15	Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design Nature Structural & Molecular Biology ·Abhay Kotecha, Julian Seago, Katherine Scott, Alison Burman, Silvia Loureiro, Jingshan Ren, Claudine Porta, Helen M. Ginn, Terry Jackson, Eva Pérez-Martín, C. Alistair Siebert, Guntram Paul, Juha T. Huiskonen, Ian M. Jones, Robert Esnouf, Elizabeth E. Fry, Francois F. Maree, Bryan Charleston, David I. Stuart	2015	84
16	Modulation of Fibroblast Growth Factor-2 Receptor Binding, Signaling, and Mitogenic Activity by Heparin-Mimicking Polysulfonated Compounds Molecular Pharmacology ·Sandra Liekens, Daria Leali, Johan Neyts, Robert Esnouf, Marco Rusnati, Patrizia Dell’Era, Prabhat C. Maudgal, Erik De Clercq, Marco Presta	1999	84
17	Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur The EMBO Journal ·James Brown, Robert Esnouf, Margaret A. Jones, Jane Linnell, Karl Harlos, A. Bassim Hassan, E. Yvonne Jones	2002	83
18	Missense Mutations in the Homeodomain of HOXD13 Are Associated with Brachydactyly Types D and E The American Journal of Human Genetics ·David Johnson, Shih‐hsin Kan, Michael Oldridge, Richard C. Trembath, Philippe Roche, Robert Esnouf, Henk Giele, Andrew O.M. Wilkie	2003	76
19	Design, Synthesis, and Enzymatic Evaluation of Multisubstrate Analogue Inhibitors of Escherichia coli Thymidine Phosphorylase Journal of Medicinal Chemistry ·A. Esteban-gamboa, Jan Balzarini, Robert Esnouf, Erik De Clercq, María‐José Camarasa, María‐Jesús Pérez‐Pérez	2000	75
20	Crystal Structures of HIV-1 Reverse Transcriptase in Complex with Carboxanilide Derivatives^, Biochemistry ·Jingshan Ren, Robert Esnouf, Andrew L. Hopkins, Jonathan Warren, Jan Balzarini, David I. Stuart, D.K. Stammers	1998	68

About Robert Esnouf

Robert Esnouf is a scholar working on Molecular Biology, Infectious Diseases, Virology, Materials Chemistry and Epidemiology, having authored 77 papers that have together received 6.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (19 papers), Biochemical and Molecular Research (15 papers), Enzyme Structure and Function (14 papers), Herpesvirus Infections and Treatments (9 papers), DNA and Nucleic Acid Chemistry (9 papers), Protein Structure and Dynamics (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (2.0k citations), Molecular Biology (3.7k citations), Immunology and Allergy (186 citations) and Immunology (613 citations). Robert Esnouf has collaborated with scholars based in United Kingdom, Belgium and Germany. Frequent co-authors include E. Yvonne Jones, David I. Stuart, D.K. Stammers, Jingshan Ren, Carl Ross, Erik De Clercq, Andrew L. Hopkins, Karl Harlos, Jan Balzarini and Jan Balzarini. Their work appears in journals such as Molecular Pharmacology, Helvetica Chimica Acta, Nature Structural & Molecular Biology, Journal of Medicinal Chemistry and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Robert Esnouf

Impact in

Papers in i

In The Last Decade

Robert Esnouf

Robert Esnouf's Hit Papers

Peers

Countries citing papers authored by Robert Esnouf

Fields of papers citing papers by Robert Esnouf

All Works

About Robert Esnouf

Explore authors with similar magnitude of impact

Papers in